Bladder cancer trials in Latvia
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingResearch participation
A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013
- Where
- Daugavpils, Liepaja, Riga
- Age
- 18 years and over
- People
- 33 worldwide
- Run by
- Urogen Pharma Ltd.
See details and how to join2026-526359-75-00EU 2026-526359-75-00Registry updated 2026-09-15
Phase 3RecruitingTrial-stage medicine
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Where
- Liepāja, Riga
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- UroGen Pharma Ltd.
See details and how to joinNCT06774131EU 2024-519343-15-00Registry updated 2026-09-03
All Bladder cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.